Cardiac Troponin Measuremen for Guiding Clinic

Background: Elevated cardiac troponin (cTn) in the absence of acute coronary syndromes (ACS) is associated with increased mortality in criti-cally ill patients. There are no evidence-based interventions that reduce mortality in this group. Objectives: We performed a retrospective investigation of the Veterans Administration Inpatient Evaluation Center database to determine whether drugs used in ACS (β-blockers, aspirin, and statins) are associated with re-based treatments known to reduce mortality in this high risk popu-10 were used to create indicators to determine if a patient was given β-blockers, aspirin, and/or statins within 24 hours of troponin el-ORIGINAL ARTICLEwhere it is permissible to download and share the work provided it is prop-erly cited. The work cannot be changed in any way or used commercially.analysis as treatment often involves β-blockers, aspirin, or statins (n = 7734). Lastly, we focused on patients who had cTn measured and for whom cTn ranges could be determined (n = 19,979) for the mortality analysis. Surgical procedures were assessed as part of the severity of illness. BarcodeMedication Administration file